TY - JOUR
T1 - Genetic modification approaches for parasporins bacillus thuringiensis proteins with anticancer activity
AU - Suárez-Barrera, Miguel O.
AU - Visser, Lydia
AU - Rondón-Villarreal, Paola
AU - Herrera-Pineda, Diego F.
AU - Alarcón-Aldana, Juan S.
AU - Van den Berg, Anke
AU - Orozco, Jahir
AU - Pinzón-Reyes, Efraín H.
AU - Moreno, Ernesto
AU - Rueda-Forero, Nohora J.
N1 - Funding Information:
The work has been funded by MINCIENCIAS, MINEDUCACI?N, MINCIT and ICETEX, through the Program Ecosistema Cient?fico Cod. FP44842-211-2018, Project number 58668.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Bacillus thuringiensis (Bt) is a bacterium capable of producing Cry toxins, which are recognized for their bio-controlling actions against insects. However, a few Bt strains encode proteins lacking insecticidal activity but showing cytotoxic activity against different cancer cell lines and low or no cytotoxicity toward normal human cells. A subset of Cry anticancer proteins, termed parasporins (PSs), has recently arisen as a potential alternative for cancer treatment. However, the molecular receptors that allow the binding of PSs to cells and their cytotoxic mechanisms of action have not been well established. Nonetheless, their selective cytotoxic activity against different types of cancer cell lines places PSs as a promising alternative treatment modality. In this review, we provide an overview of the classification, structures, mechanisms of action, and insights obtained from genetic modification approaches for PS proteins.
AB - Bacillus thuringiensis (Bt) is a bacterium capable of producing Cry toxins, which are recognized for their bio-controlling actions against insects. However, a few Bt strains encode proteins lacking insecticidal activity but showing cytotoxic activity against different cancer cell lines and low or no cytotoxicity toward normal human cells. A subset of Cry anticancer proteins, termed parasporins (PSs), has recently arisen as a potential alternative for cancer treatment. However, the molecular receptors that allow the binding of PSs to cells and their cytotoxic mechanisms of action have not been well established. Nonetheless, their selective cytotoxic activity against different types of cancer cell lines places PSs as a promising alternative treatment modality. In this review, we provide an overview of the classification, structures, mechanisms of action, and insights obtained from genetic modification approaches for PS proteins.
KW - Cancer cells
KW - Cry toxins
KW - Genetic improvement
KW - Parasporins
UR - http://www.scopus.com/inward/record.url?scp=85121542572&partnerID=8YFLogxK
U2 - 10.3390/molecules26247476
DO - 10.3390/molecules26247476
M3 - Artículo de revisión
C2 - 34946558
AN - SCOPUS:85121542572
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
IS - 24
M1 - 7476
ER -